Skip to Content

Join the 'Urinary Tract Infection' group to help and get support from people like you.

Urinary Tract Infection News

Related terms: Acute Bacterial Cystitis, Catheter-Associated Urinary Tract Infection (UTI), Chronic Urinary Tract Infection (UTI), Cystitis, acute bacterial, Infection, Urinary Tract, UTI, Catheter-Associated Urinary Tract Infection, Chronic Urinary Tract Infection, Urinary Infection

Dangerous Urinary Tract Infections Common in Nursing Homes

Posted 10 Jun 2016 by

FRIDAY, June 10, 2016 – Urinary tract infections (UTIs) in nursing home residents can often have serious effects, including delirium, debilitating falls and even fatal blood infections. Now, new research finds the infections are common in nursing homes, often due to a lack of proper prevention. UTIs "can have a devastating impact on frail, debilitated individuals," said Donna Armellino, a nurse and vice president of infection prevention at Northwell Health, in Lake Success, N.Y. She reviewed the new findings. "It is obvious, based on this random survey of nursing homes, that there is a lack of education and inconsistent practices that can raise the risk for infection," she said. In younger people, UTIs can be a painful nuisance that is usually treated with an antibiotic. But in the infirm elderly, the risk to health can be much greater, another expert explained. "UTIs in the elderly ... Read more

Related support groups: Urinary Tract Infection, Bladder Infection, Kidney Infections, Prevention of Bladder infection, Urinary Alkalinization, Cystitis Prophylaxis, Candida Urinary Tract Infection, Urinary Acidification, Pyelonephritis, Hemorrhagic Cystitis Prophylaxis

Program Cut Catheter-Associated Urinary Tract Infections

Posted 2 Jun 2016 by

WEDNESDAY, June 1, 2016 – If you find yourself hospitalized, you've got a one in five chance of needing a urinary catheter – raising your risk for a urinary tract infection. Now, researchers report that a new program shows it might be possible to reduce both catheter use and its associated infections. "Catheter-associated urinary tract infections are common and costly patient safety problems," said lead researcher Dr. Sanjay Saint. He is a professor of internal medicine at the University of Michigan in Ann Arbor. Roughly 250,000 such infections occur in hospitals each year in the United States, costing about $250 million, the researchers pointed out. Although about 20 percent of hospitalized patients get a urinary catheter, one-third of the time they aren't needed, Saint said. He believes that patients can play a role in reducing catheter use. "A lot of patients and families don't ... Read more

Related support groups: Urinary Tract Infection, Bladder Infection, Kidney Infections, Prevention of Bladder infection, Urinary Alkalinization, Cystitis Prophylaxis, Candida Urinary Tract Infection, Urinary Acidification, Pyelonephritis

U.S. Officials Confirm Superbug Resistant to All Antibiotics

Posted 27 May 2016 by

FRIDAY, May 27, 2016 – U.S. researchers have identified the nation's first patient with an infection resistant to all existing antibiotics. Scientists have warned for years the day could come when "superbugs" resisted all last-resort antibiotics. This new case, involving a 49-year-old Pennsylvania woman, suggests that day may soon be here. "It is the end of the road for antibiotics unless we act urgently," Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, said at a National Press Club event in Washington, D.C., on Thursday. Although the patient survived, it's feared the resistance could spread to other bacteria, according to media reports. The woman was treated last month for a urinary tract infection at a military clinic in Pennsylvania. The culprit was identified as E. coli bacteria. It's a common type of germ. But in this case, tests showed it was ... Read more

Related support groups: Urinary Tract Infection, Bladder Infection, Trimethoprim, Nitrofurantoin, Macrobid, Prevention of Bladder infection, Macrodantin, Methenamine, Ertapenem, Hiprex, Meropenem, Cystitis Prophylaxis, Cystex, Invanz, Monurol, Methylene Blue, Urex, Fosfomycin, Merrem, Mandelamine

FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs: Drug Safety Communication - FDA Advises Restricting Use for Certain Uncomplicated Infections

Posted 13 May 2016 by

ISSUE: FDA is advising that the serious side effects associated with fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated urinary tract infections who have other treatment options. For patients with these conditions, fluoroquinolones should be reserved for those who do not have alternative treatment options. An FDA safety review has shown that fluoroquinolones when used systemically (i.e. tablets, capsules, and injectable) are associated with disabling and potentially permanent serious side effects that can occur together. These side effects can involve the tendons, muscles, joints, nerves, and central nervous system. As a result, FDA is requiring the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs to be updated to reflect this new safety information. FDA is continuing to investigate ... Read more

Related support groups: Urinary Tract Infection, Sinusitis, Bronchitis, Cipro, Ciprofloxacin, Levaquin, Levofloxacin, Avelox, Ofloxacin, Moxifloxacin, Gatifloxacin, Gemifloxacin, Norfloxacin, Factive, Sparfloxacin, Floxin, Lomefloxacin, Nalidixic Acid, Noroxin, Cipro XR

Antibiotic Resistance Common in Kids' Urinary Tract Infections

Posted 16 Mar 2016 by

WEDNESDAY, March 16, 2016 – Many kids who develop urinary tract infections tied to the E. coli bacteria are now failing to respond to antibiotic treatment, a new review warns. The culprit, according to the British researchers: Drug resistance, following years of over-prescribing and misusing antibiotics. "Antimicrobial resistance is an internationally recognized threat to health," noted study author Ashley Bryce, a doctoral fellow at the Center for Academic Primary Care at the University of Bristol in the U.K. And that threat is of particular concern among young patients, the authors said, given that E. coli-driven urinary tract infections (UTIs) are one of the most common forms of pediatric bacterial infections. Young children are more vulnerable to complications including kidney scarring and kidney failure, so they require prompt, appropriate treatment, added Bryce and co-author ... Read more

Related support groups: Urinary Tract Infection, Amoxicillin, Bactrim, Bladder Infection, Augmentin, Trimethoprim, Kidney Infections, Bactrim DS, Amoxicillin/Clavulanate, Sulfamethoxazole/Trimethoprim, Amoxil, Prevention of Bladder infection, Septra, Prevpac, Septra DS, SMZ-TMP DS, Cotrimoxazole, Sulfatrim, Amoxil Pediatric Drops, Urinary Alkalinization

Cranberry Juice for Urinary Tract Infection?

Posted 26 Feb 2016 by

THURSDAY, Feb. 25, 2016 – Contrary to popular belief, cranberry juice does not cure a urinary tract infection, a doctor says. Many people drink cranberry juice in an attempt to ease their symptoms, but it will do nothing to help them, said Dr. Timothy Boone, vice dean of the Texas A&M Health Science Center College of Medicine, Houston campus. "Cranberry juice, especially the juice concentrates you find at the grocery store, will not treat a UTI [urinary tract infection] or bladder infection," he said in a center news release. "It can offer more hydration and possibly wash bacteria from your body more effectively, but the active ingredient in cranberry is long gone by the time it reaches your bladder," Boone said. Each year, more than 3 million Americans have a urinary tract infection – an infection in any part of the urinary system, kidney, bladder or urethra, according to the news ... Read more

Related support groups: Urinary Tract Infection, Bladder Infection, Kidney Infections, Cranberry, Prevention of Bladder infection, Cystitis Prophylaxis, Azo-Cranberry, Pyelonephritis, Ellura, Alkylating Agent Cystitis, TheraCran HP, TheraCran

Improper Antibiotic Use Often Due to Misdiagnosis: Study

Posted 20 May 2015 by

WEDNESDAY, May 20, 2015 – Misdiagnosis often leads to improper antibiotic use in hospitals, new research finds. Incorrect antibiotic use can cause patient harm, reduce the effectiveness of antibiotics and increase health care costs, the researchers noted. "Antibiotic therapies are used for approximately 56 percent of inpatients in U.S. hospitals, but are found to be inappropriate in nearly half of these cases, and many of these failures are connected with inaccurate diagnoses," study author Dr. Greg Filice said in a news release from the Society for Healthcare Epidemiology of America. Filice, an internist with the Minneapolis Veterans Affairs Health Care System, and his colleagues analyzed 500 inpatient cases at the Minneapolis VA Medical Center. They found that inappropriate use of antibiotics occurred with 95 percent of patients who received an incorrect or indeterminate diagnosis, ... Read more

Related support groups: Urinary Tract Infection, Metronidazole, Bactrim, Bladder Infection, Pneumonia, Flagyl, Kidney Infections, Bactrim DS, Sulfamethoxazole/Trimethoprim, Xifaxan, Polymyxin B, Septra, Zyvox, Sepsis, Rifaximin, Metro, Bacitracin, Chloramphenicol, Septra DS, SMZ-TMP DS

FDA Medwatch Alert: Zerbaxa (ceftolozane and tazobactam): Drug Safety Communication - FDA Cautions about Dose Confusion and Medication Errors

Posted 20 May 2015 by

ISSUE: The U.S. Food and Drug Administration (FDA) is warning health care professionals about the risk for dosing errors with the antibacterial drug Zerbaxa (ceftolozane and tazobactam) due to confusion about the drug strength displayed on the vialand carton labeling. (See the Drug Safety Communication for Label Photos). FDA evaluated seven reported cases of medication error that occurred during preparation of the dose in the pharmacy due to confusion with the display of the strength of individual ingredients on Zerbaxa’s vial labels and carton labeling. Listing the individual drug strengths led to confusion because it was different from labeling for other drugs in the beta-lactam/beta-lactamase class that express strength as the sum of the two active ingredients. In some cases, this led to administration of 50% more drug than was prescribed. No adverse events were reported among these s ... Read more

Related support groups: Urinary Tract Infection, Intraabdominal Infection, Ceftolozane/tazobactam, Zerbaxa

Health Tip: Spotting Signs of Urinary Tract Infection

Posted 1 May 2015 by

-- A urinary tract infection (UTI) occurs when bacteria become prolific in the bladder, kidneys or elsewhere in the urinary tract. The National Kidney and Urologic Diseases Information Clearinghouse says symptoms of UTI may include: A burning sensation during urination. The frequent need to urinate, though often passing little urine. Pain in the side below the ribs or in the back. Bloody or cloudy urine that may have a bad odor. Chills or fever. Read more

Related support groups: Urinary Tract Infection, Bladder Infection, Kidney Infections, Urinary Alkalinization, Pyelonephritis

Study Casts Doubt on Use of Common Antibiotic for UTIs in Women

Posted 30 Apr 2015 by

THURSDAY, April 30, 2015 – The antibiotic most commonly prescribed for bladder and other urinary tract infections, nitrofurantoin, may not be the most effective option, new research suggests. More than 25 percent of older adults have reduced kidney function, and bladder infections are a common complaint. Doctors often turn to nitrofurantoin to treat these and other urinary tract infections (UTIs), but concerns have been raised about the ability of the drug to reach the urinary tract and target bacteria that causes bladder infections, especially in those with poor kidney function. The new Canadian research was led by Dr. Amit Garg, a nephrologist at Western University in London, Ontario. His team compared the benefits of nitrofurantoin to the effectiveness of other commonly used antibiotics such as ciprofloxacin ("Cipro") and norfloxicin. The study, published recently in the Canadian ... Read more

Related support groups: Urinary Tract Infection, Metronidazole, Bactrim, Bladder Infection, Cipro, Ciprofloxacin, Levaquin, Flagyl, Nitrofurantoin, Macrobid, Kidney Infections, Levofloxacin, Bactrim DS, Avelox, Sulfamethoxazole/Trimethoprim, Xifaxan, Polymyxin B, Prevention of Bladder infection, Septra, Macrodantin

New Antibiotic Avycaz Approved

Posted 26 Feb 2015 by

THURSDAY, Feb. 26, 2015 – The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, including the kidneys. Avycaz contains the previously approved antibiotic ceftazidime, and the newer antibacterial drug avibactam, the agency said in a news release. Approved to help combat antibacterial resistance, Avycaz is sanctioned for people who have limited or no other treatment options, the FDA said. The most common side effects identified during clinical testing included vomiting, nausea, constipation and anxiety. Users with poor kidney function had more serious adverse reactions including decreased effectiveness and seizures, the agency said. And users allergic to penicillin may be at greater risk of serious skin reactions and anaphylaxis, the FDA ... Read more

Related support groups: Urinary Tract Infection, Kidney Infections, Intraabdominal Infection, Pyelonephritis

FDA Approves Avycaz (ceftazidime and avibactam) for Complicated Abdominal and Urinary Tract Infections

Posted 25 Feb 2015 by

February 25, 2015 – The U.S. Food and Drug Administration today approved Avycaz (ceftazidime-avibactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no alternative treatment options. Avycaz contains two drugs: ceftazidime, a previously approved cephalosporin antibacterial drug, and avibactam, to help extend bacterial resistance. “The FDA is committed to making therapies available to treat patients with unmet medical need,” said Edward Cox, M.D., M.P.H, director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research. “It is important that the use of Avycaz be reserved to situations when there are limited or no alternative antibacterial drugs fo ... Read more

Related support groups: Urinary Tract Infection, Intraabdominal Infection

Health Tip: Help Prevent Urinary Tract Infections Among Children

Posted 27 Jan 2015 by

-- There are things parents can do to help prevent urinary tract infections among children. The National Kidney and Urologic Diseases Information Clearinghouse offers these suggestions: Encourage your child to use the bathroom regularly. If your child doesn't urinate frequently, offer more fluids. Make sure your child knows how to properly wipe after using the bathroom. Dress your child in cotton underwear and loosely fitted clothing. Read more

Related support groups: Urinary Tract Infection

Combination Antibiotic Zerbaxa Approved

Posted 22 Dec 2014 by

MONDAY, Dec. 22, 2014 – The combination antibiotic Zerbaxa (ceftolozane/tazobactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated abdominal infections and complicated urinary tract infections. The approval for abdominal infections was approved in combination with another drug, metronidazole, the agency said in news release. The approval for urinary tract infection includes infection of the kidney. Zerbaxa is the fourth antibiotic to be FDA-approved in 2014, following approval of Dalvance (dalbavancin), Sivextro (tedizolid) and Orbactiv (oritavancin). The drug's label includes a warning about decreased effectiveness among people with kidney impairment, the FDA said. The most common side effects reported during clinical testing included nausea, diarrhea, headache and fever. Zerbaxa is marketed by Cubist Pharmaceuticals, based in Lexington, ... Read more

Related support groups: Urinary Tract Infection, Intraabdominal Infection

FDA Approves Zerbaxa (ceftolozane/tazobactam) for Complicated Intra-Abdominal/Urinary Tract Infections

Posted 19 Dec 2014 by

December 19, 2014 – The U.S. Food and Drug Administration today approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI). Zerbaxa is a combination product containing ceftolozane, a cephalosporin antibacterial drug, and tazobactam, a beta-lactamase inhibitor. Zerbaxa is used to treat cUTI, including kidney infection (pyelonephritis). It is used in combination with metronidazole to treat cIAI. Zerbaxa is the fourth new antibacterial drug approved by the FDA this year. The agency approved Dalvance (dalbavancin) in May, Sivextro (tedizolid) in June and Orbactiv (oritavancin) in August. “The FDA approval of several new antibacterial drugs this year demonstrates the agency’s commitment to increasing the availability of treatment options for patients and phy ... Read more

Related support groups: Urinary Tract Infection, Intraabdominal Infection

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Bladder Infection, Kidney Infections, Pyelonephritis, Candida Urinary Tract Infection, Urinary Alkalinization, Urinary Acidification, Infections

Related Drug Support Groups

amoxicillin, doxycycline, Bactrim, Cipro, ciprofloxacin, Augmentin, Levaquin, trimethoprim, nitrofurantoin, view more... Macrobid, levofloxacin, Bactrim DS, amoxicillin / clavulanate, cefuroxime, sulfamethoxazole / trimethoprim, Acidophilus, cranberry, Rocephin, ampicillin, Doryx, Amoxil, Macrodantin, Septra, Ceftin, cefixime, ofloxacin, ceftriaxone, cefadroxil, amikacin, Prosed DS, SMZ-TMP DS, Septra DS, Ceclor, Uribel, Doxy Lemmon, Monodox, methenamine, Sulfatrim, cefotaxime, cefaclor, Ancef, cefepime, ertapenem, Hiprex, Vibramycin, Doxy 100, Urimax, cefazolin, gatifloxacin, gotu kola, Amoclan, Duricef, norfloxacin, Zosyn, Augmentin XR, Invanz, Ustell, Hyophen, Floxin, Unasyn, Flora-Q, Urelle, Urex, Azo-Cranberry, lactobacillus acidophilus, Sulfatrim Pediatric, Timentin, Augmentin ES-600, Trimox, Vibra-Tabs, Amikin, Biomox, Suprax, Cotrim, lomefloxacin, Mandelamine, Bethaprim, Noroxin, Bactrim Pediatric, Bactrim IV, Cotrim DS, Usept, Prosed EC, Flora-Q 2, UTICAP, Co-trimoxazole, Ceclor CD, Amikin Pediatric, Utira, Primsol, Phosenamine, Urised, Doxy 200, Florajen, Maxaquin, Lithostat, piperacillin, cilastatin / imipenem, cefoperazone, cefoxitin, ceftazidime, Fortaz, bilberry, Cipro IV, Cefizox, Cipro XR, Uritin, Primaxin IM, Phosphasal, Urogesic Blue, Zinacef, MHP-A, Uramit MB, Mezlin, MSP-Blu, TheraCran HP, Hyolev MB, Utira-C, Uro-L, UriSym, Uro-MP, Uritact DS, Uro Blue, Urimar-T, Azo Gantanol, Uretron DS, Dolsed, Uretron, Atrosept, UroAv-B, Cystemms-V, Indiomin MB, Urolet MB, Urapine, Cefobid, Azuphen MB, TheraCran, Utrona, RisaQuad, UR N-C, Oraxyl, Doribax, Tequin Teqpaq, Uritact -EC, Darcalma, Apo-Amoxi, Utrona-C, Darpaz, Morgidox, Bacid (LAC), Levaquin Leva-Pak, Ocudox, Novaflor, Azo Gantrisin, Avycaz, Risa-Bid, Urin D / S, Zerbaxa, Ellura, Methylphen, Azo-Truxazole, Superdophilus, RisaQuad 2, Ceptaz, avibactam / ceftazidime, Azactam, Maxipime, hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate, ceftolozane / tazobactam, ticarcillin, doripenem, hyoscyamine / methenamine / methylene blue / sodium biphosphate, Claforan, Cefotan, Ticar, Proloprim, Raniclor, Furadantin, Tequin, Mefoxin, Tazicef, pitcher plant, piperacillin / tazobactam, cefotetan, ceftizoxime, cinoxacin, cefonicid, cefamandole, ampicillin / sulbactam, aztreonam, clavulanate / ticarcillin, enoxacin, oxytetracycline / phenazopyridine / sulfamethizole, phenazopyridine / sulfamethoxazole, phenazopyridine / sulfisoxazole, netilmicin, mezlocillin, hyoscyamine / methenamine / methylene blue / phenyl salicylate, methenamine / sodium biphosphate, Principen, DisperMox, Nitro Macro, Floxin IV, Trimpex, Netromycin, Penetrex, Amoxicot, Moxilin, Uroplus, Uroplus DS, Urobiotic-250, Tija, Uro-Phosphate, Cinobac, Cotrim Pediatric, Septra IV, Bethaprim Pediatric, Wymox, Ceclor Pulvules, Totacillin-N, Kefzol, acetohydroxamic acid, Omnipen-N, Omnipen, Primaxin IV, Proquin XR, Tazidime, Tazicef Novaplus, Pipracil, Mandol, Monocid, Kefurox, Doxy-Caps, Cipro Cystitis Pack, Doxy-D, Trac Tabs 2x